DEXCOM, INC. Amortization of Intangible Assets
DEXCOM, INC. (DXCM) reported Amortization of Intangible Assets of $4.20 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-12.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2026-02-12
- DEXCOM, INC. amortization of intangible assets for the quarter ending 2023-12-31 was $2.90M, a 61.11% increase year-over-year.
- DEXCOM, INC. amortization of intangible assets for the quarter ending 2023-09-30 was $1.70M, a 5.56% decline year-over-year.
- DEXCOM, INC. amortization of intangible assets for the quarter ending 2023-06-30 was $1.70M, a 10.53% decline year-over-year.
- DEXCOM, INC. amortization of intangible assets for the quarter ending 2023-03-31 was $1.80M, a 10.00% decline year-over-year.
- DEXCOM, INC. amortization of intangible assets for fiscal 2025 was $4.20M, a 37.31% decline from fiscal 2024.
- DEXCOM, INC. amortization of intangible assets for fiscal 2024 was $6.70M, a 17.28% decline from fiscal 2023.
- DEXCOM, INC. amortization of intangible assets for fiscal 2023 was $8.10M, a 8.00% increase from fiscal 2022.
- DEXCOM, INC. amortization of intangible assets for fiscal 2022 was $7.50M, a 102.70% increase from fiscal 2021.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 12 month |
|---|---|---|---|---|
| 2025-12-31 | $4.20M 10-K · filed 2026-02-12 | |||
| 2024-12-31 | $6.70M 10-K · filed 2026-02-12 | |||
| 2023-12-31 | $2.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $4.60M derived: sum of 2 quarters · filed 2026-02-12 | $6.30M derived: sum of 3 quarters · filed 2026-02-12 | $8.10M 10-K · filed 2026-02-12 |
| 2023-09-30 | $1.70M 10-Q · filed 2023-10-26 | $3.40M derived: sum of 2 quarters · filed 2023-10-26 | $5.20M 10-Q · filed 2023-10-26 | $7.00M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-06-30 | $1.70M 10-Q · filed 2023-07-27 | $3.50M 10-Q · filed 2023-07-27 | $5.30M derived: sum of 3 quarters · filed 2025-02-18 | $7.10M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-03-31 | $1.80M 10-Q · filed 2023-04-27 | $3.60M derived: sum of 2 quarters · filed 2025-02-18 | $5.40M derived: sum of 3 quarters · filed 2025-02-18 | $7.30M derived: sum of 4 quarters · filed 2025-02-18 |
| 2022-12-31 | $1.80M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $3.60M derived: sum of 2 quarters · filed 2025-02-18 | $5.50M derived: sum of 3 quarters · filed 2025-02-18 | $7.50M 10-K · filed 2025-02-18 |
| 2022-09-30 | $1.80M 10-Q · filed 2023-10-26 | $3.70M derived: sum of 2 quarters · filed 2023-10-26 | $5.70M 10-Q · filed 2023-10-26 | $7.10M derived: sum of 4 quarters · filed 2024-02-08 |
| 2022-06-30 | $1.90M 10-Q · filed 2023-07-27 | $3.90M 10-Q · filed 2023-07-27 | $5.30M derived: sum of 3 quarters · filed 2024-02-08 | $6.60M derived: sum of 4 quarters · filed 2024-02-08 |
| 2022-03-31 | $2.00M 10-Q · filed 2023-04-27 | $3.40M derived: sum of 2 quarters · filed 2024-02-08 | $4.70M derived: sum of 3 quarters · filed 2024-02-08 | $5.20M derived: sum of 4 quarters · filed 2024-02-08 |
| 2021-12-31 | $1.40M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-08 | $2.70M derived: sum of 2 quarters · filed 2024-02-08 | $3.20M derived: sum of 3 quarters · filed 2024-02-08 | $3.70M 10-K · filed 2024-02-08 |
| 2021-09-30 | $1.30M 10-Q · filed 2022-10-27 | $1.80M derived: sum of 2 quarters · filed 2022-10-27 | $2.30M 10-Q · filed 2022-10-27 | |
| 2021-06-30 | $500.00K 10-Q · filed 2022-07-28 | $1.00M 10-Q · filed 2022-07-28 | ||
| 2020-12-31 | $2.50M 10-K · filed 2023-02-09 | |||
| 2016-12-31 | $700.00K 10-K · filed 2017-02-28 | |||
| 2015-12-31 | $500.00K 10-K · filed 2017-02-28 | |||
| 2014-12-31 | $600.00K 10-K · filed 2017-02-28 | |||
| 2013-12-31 | $600.00K 10-K · filed 2016-02-23 | |||
| 2012-12-31 | $500.00K 10-K · filed 2015-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |